MolDX Local Coverage Determination (LCD) and Medical Coverage Database (MCD) Article Updates: Part A and Part B
Published 10/15/2021
The following MolDX LCDs were revised:
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer L37870
- MolDX: MGMT Promoter Methylation Analysis L35974
The following MCD Articles were revised:
- Billing and Coding: MolDX: MGMT Promoter Methylation Analysis A56941
- Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer A54795
- Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) A56593
- Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells A58021
- Billing and Coding: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer A56924
The following MolDX LCDs were retired:
- MolDX: Prolaris™ Prostate Cancer Genomic Assay L35869
- MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease L37043
The following MCD Articles were retired: